ADVERTISEMENT

Breast Cancer Call to Rehabilitation & Exercise Action

BY KATHY LATOUR
PUBLISHED SATURDAY, JUNE 16, 2012
A concert pianist was told not to play the piano after breast cancer surgery because it could cause lymphedema.

A young mother couldn’t lift her baby because of shoulder weakness two years after treatment.

“It’s a travesty,” says physical therapist Jill Binkley, founder of TurningPoint Women’s Healthcare, a nonprofit breast cancer rehabilitation clinic in Atlanta. “We are seeing 300 women a year in our clinic, and it’s the tip of the iceberg. These are all women who have breast cancer and have ongoing issues because of surgery and other treatments.”

Binkley, who is a 12-year survivor of stage 3 breast cancer, joined other researchers who recognized women’s unmet physical needs and the increasing evidence for an expanded rehabilitation approach for breast cancer patients. As a result she became part of the planning committee of an early 2011 meeting of leaders and stakeholders in the area of breast cancer rehabilitation and exercise that was supported by the American Cancer Society. The result of the meeting is a special supplement published in April in the journal Cancer??: “A Prospective Surveillance Model for Rehabilitation for Women with Breast Cancer.” The articles explore rehabilitation and exercise as they relate to ongoing efforts to devise creative, multidisciplinary solutions to address the physical and functional needs of the growing population of breast cancer survivors. (You can read the supplement here.)

“A prospective surveillance model means each woman receives a pre-surgery baseline, post-surgery assessment and ongoing surveillance for the physical side effects of treatment,” says Binkley. The model is a proactive approach to periodically examining patients during and after disease treatment, in an effort to enable early detection of and intervention for physical impairments known to be associated with cancer treatment. Women are educated throughout the process of surveillance about the benefits of exercise and the importance of early rehabilitation intervention when physical or functional impairments are identified.

There is a compelling body of evidence that rehabilitative and exercise interventions benefit breast cancer survivors.

“There has been broad agreement that there is a compelling body of evidence that rehabilitative and exercise interventions benefit breast cancer survivors and that establishing better ways of connecting survivors with these interventions is warranted,” says Kathryn Schmitz, PhD, of the Abramson Cancer Center of the University of Pennsylvania, Philadelphia. Recommendations in the supplement include:

> Promoting surveillance for common physical impairments and functional limitations associated with breast cancer treatment;

> Providing education to reduce risk or prevent adverse effects and facilitate early identification of physical impairments and functional limitations;

> Introducing rehabilitation and exercise interventions when physical impairments are identified; and

> Promoting and supporting physical activity, exercise and weight-management behaviors through the trajectory of disease treatment and survivorship.

Additional articles in the supplement address the challenges of integrating the model into survivorship care delivery, as well as exploring the model in relation to long-term issues of follow-up; post-reconstructive issues; upper body and lymphedema issues; treatment’s impact on the development of chemotherapy-induced peripheral neuropathy; cancer-related fatigue; cardiac toxicity; weight management; bone health; physical function; clinical practice guidelines; cost considerations and stakeholder perspectives. Binkley says she hopes the supplement will draw attention to the unmet needs of women with breast cancer, make rehabilitation and exercise a routine part of their care and offer hope for improved quality of life. 

ADVERTISEMENT
Related Articles
Chemobrain—It’s Real, It’s Complex, and the Science Is Still Evolving
BY SUSAN KRIGEL, PHD
Talk with almost any cancer survivor, and he or she is likely to bring up the topic of “chemobrain,” that fuzzy, murky state that patients blame for impaired memory. A review of the research shows how we're focusing on the problem.
“Cross-Pollination” of Breast Cancer Knowledge was Encouraged at SABCS
BY DEBU TRIPATHY, MD
While science sometimes moves forward in quantum leaps, it more often advances in small steps, and this year’s San Antonio Breast Cancer Symposium demonstrated both sides of that coin.
Dating, Love, Sex ... and Cancer
I went into dating after cancer with one goal, a decent date, and I got far more than I ever dreamed.
Is Radiation Therapy in Early-Stage Breast Cancer Always Necessary?
BY FRANK A. VICINI, MD
Women diagnosed with early-stage breast cancer have a variety of decisions to make regarding treatment, but it's important for patients to realize all of their options when making those medical decisions.
Ibrance Approved for Metastatic Breast Cancer
BY SILAS INMAN
The anticipated approval of Ibrance (palbociclib) came two months ahead of expectations, as the FDA granted an accelerated approval to the drug as a frontline treatment for women with ER-positive, HER2-negative metastatic breast cancer.
Related Videos
Medical Updates from the 32nd Annual Miami Breast Cancer Conference
The evolution of the treatment for hormone receptor-positive breast cancer was a hot topic for this year's Miami Breast Cancer Conference. Debu Tripathy, CURE's editor-in-chief and breast oncologist, reports from the meeting.
Joan Lunden Discusses the Physical and Emotional Effects of Breast Cancer Treatment
Journalist Joan Lunden shares her experience with breast cancer, side effects and working through treatment.
Journalist Joan Lunden Discusses Her Breast Cancer Diagnosis and Treatment
Roy Firestone interviews longtime journalist, author and television host Joan Lunden on her recent breast cancer diagnosis and treatment.
Breast Oncologist Beth Overmoyer Explains Results of Ovarian Suppression
Beth Overmoyer, a breast oncologist at Dana-Farber Cancer Institute, speaks on the results of the SOFT trial and its potential impact on young women with hormone receptor-positive breast cancer.
SABCS: Debu Tripathy Discusses Hormonal Therapy Advances in Breast Cancer
Debu Tripathy reports on recent studies involving hormone therapy in estrogen receptor-positive breast cancer.
Recent Publications
  • photo
    photo
    photo
    photo
    photo
  • photo
    photo
    photo
    photo
    photo
ADVERTISEMENT
$auto_registration$